SGAM
AMRX icon

Smith Group Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Smith Group Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,190
Closed -$20K – 278
2021
Q4 		$20K Hold
4,190
– – ﹤0.01% 253
2021
Q3 		$22K Hold
4,190
– – ﹤0.01% 229
2021
Q2 		$21K Buy
4,190
+1,200
+40% +$6.82K ﹤0.01% 230
2021
Q1 		$20K Sell
2,990
-69,640
-96% -$386K ﹤0.01% 207
2020
Q4 		$332K Sell
72,630
-101,130
-58% -$448K 0.02% 154
2020
Q3 		$674K Sell
173,760
-60
-0% -$257 0.04% 116
2020
Q2 		$827K Buy
+173,820
New +$716K 0.05% 108
2018
Q4 		– Sell
-110,980
Closed -$2.46M – 449
2018
Q3 		$2.46M Buy
+110,980
New +$2.34M 0.07% 121

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return